I'll be very quick, then, and will comment on the special access program and regulations.
First, the special access program, which was amended in January of this year to facilitate psilocybin use, is a complete and total failure. Eighteen patients have been granted access. Val Masuda, the doctor of one of your constituents, can attest to the fact that SAP was a failure. Health Canada is now telling us and many of the doctors and patients that they are to not use the SAP and to use clinical trials, which is wrong here.
We need regulations. We need medical regulations. Our organization has written those medical regulations and submitted them to the ministers of health. Those medical regulations fall right in line with the medical cannabis regulations, which, again, are based upon human rights. That's what we're looking for—the human right to try psilocybin, especially for those for whom it works.